Determinants of health care use in a population-based leukodystrophy cohort

Area of Science:

• Pediatric rare diseases
• Healthcare economics
• Clinical resource utilization

Background:

• Leukodystrophies are a group of rare genetic disorders affecting myelin development in the central nervous system.
• Understanding the economic burden of these conditions is crucial for resource allocation and care management.

Purpose of the Study:

• To quantify healthcare costs associated with pediatric leukodystrophies.
• To identify clinical features and resource use patterns linked to high healthcare expenditures.

Main Methods:

• A population-based cohort study of 122 patients with leukodystrophies over a 9-year period.
• Analysis of inpatient, outpatient, and emergency department healthcare utilization and costs.
• Comparison of healthcare use between high-cost (>85th percentile) and lower-cost patient groups.

Main Results:

• Significant variability in resource use was observed, with the top 15% of patients accounting for 73% of total costs ($9.6 million).
• Inpatient hospitalizations represented the largest cost driver (81%, $10.8 million).
• High-cost patients experienced more frequent and prolonged hospitalizations, higher intensive care unit (ICU) and mechanical ventilation needs, and increased infection rates. Bone marrow transplantation did not solely explain cost differences.

Conclusions:

• Inpatient hospitalization is the primary driver of healthcare resource use in pediatric leukodystrophy patients.
• A small subset of patients incurs a disproportionately large share of healthcare costs, largely due to increased hospitalization volume.
• Future cost-reduction strategies should focus on minimizing inpatient stays and addressing modifiable factors contributing to hospitalizations.